Trials / Sponsors / Cingulate Therapeutics
Cingulate Therapeutics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) Healthy Volunteers in Fed and Fasted State | Phase 1 | 2024-10-31 |
| Completed | Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 ADHD, Attention Deficit Hyperactivity Disorder, ADHD - Combined Type | Phase 3 | 2023-08-01 |
| Suspended | Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity | Phase 3 | 2023-07-31 |
| Completed | Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. ADHD, ADHD - Combined Type, Attention Deficit Hyperactivity Disorder Combined | Phase 3 | 2022-12-29 |
| Completed | Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects Healthy Volunteers in Fed and Fasted State | Phase 1 | 2022-09-14 |
| Completed | CTx-1301 Comparative Bioavailability Study ADHD | Phase 1 / Phase 2 | 2019-12-06 |